Remarkable Results in the Treatment of Patients with Relapsed Large B-Cell Lymphoma
Directly from ASH21 we offer you an update from the ZUMA‑7 study, A Phase 3 Randomized Trial of Axi-Cel Treatment for patients with relapsed large B-Cell Lymphoma. The results are remarkable, Axi-Cel Treatment is one of the new treatments for lymphoma patients that will likely become a new paradigm in the future. In this MEDtalk Frederik L. Locke, sums up the background of the study and presents the convincing results.
Get access to the article
If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.